Table 2.

Serum biomarkers at the time of HCC diagnosis and at LT listing

Serum Biomarker	Median (IQR) or n (%)
Median AFP at diagnosis (ng/mL) (n=244)	9.0 (IQR 4.1–31.8)
Median AFP at listing (n=267)	7.0 (IQR 3.4–21.5)
AFP at listing ≥20	75 (28.1)
AFP at listing ≥100	22 (8.2)
AFP at listing ≥250	12 (4.5)
Median AFP-L3% at diagnosis (n=60)	9.2 (IQR 5.5–19.3)
Median AFP-L3% at listing (n=267)	7.1 (IQR 0.5–12.5)
AFP-L3 at listing ≥15%	58 (21.7)
AFP at listing ≥35%	24 (9.0)
Absolute AFP-L3 at listing ≥5 ng/mL	48 (18.0)
Absolute AFP-L3 at listing ≥10 ng/mL	36 (13.5)
Median DCP at diagnosis (ng/mL) (n=55)	1.3 (IQR 0.2–5.6)
Median DCP at listing (n=267)	1.0 (IQR 0.2–3.8)
DCP at listing ≥7.5	47 (17.7)